Trial Condition(s):

Male, Hypogonadism

Use of Nebido® to assess tolerability and treatment outcomes in daily clinical practice (IPASS Nebido)

Bayer Identifier:

14203

ClinicalTrials.gov Identifier:

NCT00410306

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This is an observational study with a drug called Nebido, a new testosterone replacement therapy, which is available for the treatment of male hypogonadism. The benefit and safety of Nebido have already been thoroughly evaluated through well controlled clinical trials. The main purpose of this observational study is to confirm the established safety profile of Nebido in daily clinical practice.

Inclusion Criteria
- Male hypogonadal patients eligible for long-term testosterone therapy who have newly been prescribed Nebido® in accordance with the terms of the marketing authorization
Exclusion Criteria
- Patients presenting with contraindications as stated in the product information

Trial Summary

Enrollment Goal
1493
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Nebido (Testosterone Undeconate, BAY86-5037)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Italy

Status
Completed
 
Locations

Investigative Site

Many Locations, Lithuania

Status
Terminated
 
Locations

Investigative Site

Many Locations, Hong Kong, China

Status
Completed
 
Locations

Investigative Site

Many Locations, Malaysia

Status
Completed
 
Locations

Investigative Site

Many Locations, Philippines

Status
Completed
 
Locations

Investigative Site

Many Locations, Thailand

Status
Completed
 
Locations

Investigative Site

Many Locations, Saudi Arabia

Status
Completed
 
Locations

Investigative Site

Many Locations, Moldova

Status
Completed
 
Locations

Investigative Site

Many Locations, Jordan

Status
Terminated
 
Locations

Investigative Site

Many Locations, Lebanon

Status
Terminated
 
Locations

Investigative Site

Many Locations, Malta

Status
Terminated
 
Locations

Investigative Site

Many Locations, Germany

Status
Completed
 
Locations

Investigative Site

Many Locations, United Kingdom

Status
Completed
 
Locations

Investigative Site

Many Locations, Spain

Status
Terminated
 
Locations

Investigative Site

Many Locations, Mexico

Status
Terminated
 
Locations

Investigative Site

Many Locations, Czech Republic

Status
Completed
 
Locations

Investigative Site

Many Locations, Australia

Status
Completed
 
Locations

Investigative Site

Many Locations, Bulgaria

Status
Completed
 
Locations

Investigative Site

Many Locations, Austria

Status
Completed
 
Locations

Investigative Site

Many Locations, Turkey

Status
Terminated
 
Locations

Investigative Site

Many Locations, Colombia

Status
Completed
 
Locations

Investigative Site

Many Locations, Russia

Status
Completed
 
Locations

Investigative Site

Many Locations, Ukraine

Status
Completed
 
Locations

Investigative Site

Many Locations, Indonesia

Status
Completed
 
Locations

Investigative Site

Many Locations, South Korea

Status
Completed
 
Locations

Investigative Site

Many Locations, Taiwan, China

Status
Completed
 
Locations

Investigative Site

Many Locations, Estonia

Status
Terminated
 
Locations

Investigative Site

Many Locations, Singapore

Status
Completed
 
Locations

Investigative Site

Many Locations, Latvia

Status
Terminated
 
Locations

Investigative Site

Many Locations, Slovenia

Status
Terminated
 
Locations

Investigative Site

Many Locations, Romania

Status
Completed
 
Locations

Investigative Site

Many Locations, Kazakhstan

Status
Completed
 
Locations

Investigative Site

Many Locations, Macedonia

Status
Completed
 

Trial Design